Miragen Therapeutics Inc (MGEN) Stock Analyst Ratings
NASDAQ:MGEN - Nasdaq -
ChartMill assigns a Buy % Consensus number of 90% to MGEN. The Buy consensus is the weighted average rating of the current analysts ratings.
MGEN was analyzed by 4 analysts. The buy percentage consensus is at 90. So analysts seem to be very confident about MGEN.
In the previous month the buy percentage consensus was at a similar level.
Only 4 analysts analyzed MGEN. So this is just the average opinion of a couple of analysts.